Table: begin end state 1 29 cytoplasmic 30 33 non-cytoplasmic 34 46 transmembrane 47 61 non-cytoplasmic 62 81 transmembrane 82 92 cytoplasmic 93 111 transmembrane 112 116 non-cytoplasmic 117 138 transmembrane 139 158 cytoplasmic 159 181 transmembrane 182 192 non-cytoplasmic 193 212 transmembrane 213 251 cytoplasmic 252 271 transmembrane 272 290 non-cytoplasmic 291 310 transmembrane 311 318 cytoplasmic 319 339 transmembrane 340 344 non-cytoplasmic 345 368 transmembrane 369 378 cytoplasmic 379 401 transmembrane 402 412 non-cytoplasmic 413 432 transmembrane 433 464 cytoplasmic
Input: >WP_058930128.1 NCBI__GCF_001484605.1:WP_058930128.1 MSTQQAEVQSEAAQTRRAVSNILKGSAGNLVEWYDLYVYTVFAAYFQSHFFNSQDDLQAG LEAMAVFSTSFLMRPVGAWFFGRYADRKGRKAALTLSVTIMSAGSFAIAILPTTQQIGVW ALILLILVRLVQGFSVGGEYGTSATYMSEAATSKRRGFFSSFQYVTLIGGQMLALLVLVI LQNTMDKGALTEWGWRIPFAIGGVAALVVLWLRRSMEETVSAEQVEAAKVPAVAGVAQPG TMKLLFTQHWKPLLICIGVTLGGTVAFYTYTNFILKFMNDTSGIAKTDTSVINFWALFIF MLLQPVYGIISDKVGRRPLLLWFGITGVLFTWPLLSTLAGTKDPFTAFLLMLGGLLIVGG YTSINALVKAELFPASIRALGVGLGYAIANSLFGGTVPLLGAAFQKAERVDLFFTYVTVA IAISLVVYIFALKNKKATHLDREQGDAWNRPAKDDDKDKDLINA
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server